Respiratory Therapeutics Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Respiratory Therapeutics Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergies
Studies from Karolinska University in the area of allergies described
May 18th, 2009
"The use of combination therapy In mild asthma Is debated. The current authors evaluated the effects of formoterol alone and a formoterol/budesonide combination Inhaler on asthma deterioration Induced by repeated low-dose allergen exposure," scientists writing in the European Respiratory Journal report. "In total, 15 subjects with intermittent allergic asthma Inhaled low doses of allergen on seven consecutive weekdays In a three-period, crossover, double-blind, double-dummy comparison between formoterol 4.5 mu g Turbuhaler (TM), budesonide 160 mu g/formoterol 4.5 mu g Turbuhaler (TM) and placebo, each taken as two puffs 30 min after allergen dosing. The outcome...
Source: Respiratory Therapeutics Week (2009-05-18)
|
